sector >>> Healthcare
fullTimeEmployees >>> 853
longBusinessSummary >>> Hutchison China MediTech Limited, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapeutics and immunotherapies for oncology and immunological diseases in the People's Republic of China. It operates through Innovation Platform and Commercial Platform segments. The company provides research and development services; and develops, manufactures, distributes, and markets prescription and over-the-counter pharmaceutical products, and consumer health products under the Baiyunshan and Shang Yao brands. Its clinical stage drugs include Savolitinib, an inhibitor for the treatment of non-small cell lung cancer, papillary renal cell carcinoma, colorectal cancer, gastric cancer, and prostate cancer; and Fruquintinib, an inhibitor for the treatment of colorectal cancer and solid tumors. The company is also developing Surufatinib, an inhibitor for the treatment of pancreatic neuroendocrine tumors and solid tumors; HMPL-523, an inhibitor for the treatment of indolent non-Hodgkin's lymphoma; and HMPL-689 for the treatment of indolent non-Hodgkin's lymphoma. In addition, it engages in the development of HMPL-453, an inhibitor for the potential treatment of solid tumors; HMPL-306, a molecule dual-inhibitor of isocitrate dehydrogenase 1 and 2 for the treatment of hematological malignancies, gliomas, and solid tumors; and clinical-stage EGFR inhibitors, such as Epitinib and theliatinib. Hutchison China MediTech Limited has a clinical collaboration agreement with BeiGene, Ltd. to evaluate the safety and efficacy of combining surufatinib and fruquintinib with BeiGenes anti-PD-1 antibody tislelizumab for the treatment of various solid tumor cancers. The company was incorporated in 2000 and is headquartered in Central, Hong Kong. Hutchison China MediTech Limited is a subsidiary of Hutchison Healthcare Holdings Limited.
city >>> Central
phone >>> 852 2121 8200
country >>> Hong Kong
companyOfficers >>> []
website >>> http://www.chi-med.com
maxAge >>> 1
address1 >>> Cheung Kong Center
fax >>> 852 2128 1778
industry >>> Biotechnology
address2 >>> 48th Floor 2 Queen's Road
previousClose >>> 31.86
regularMarketOpen >>> 31.68
twoHundredDayAverage >>> 25.438057
trailingAnnualDividendYield >>> None
payoutRatio >>> 0
volume24Hr >>> None
regularMarketDayHigh >>> 32.9
navPrice >>> None
averageDailyVolume10Day >>> 178685
totalAssets >>> None
regularMarketPreviousClose >>> 31.86
fiftyDayAverage >>> 33.44853
trailingAnnualDividendRate >>> None
open >>> 31.68
toCurrency >>> None
averageVolume10days >>> 178685
expireDate >>> None
yield >>> None
algorithm >>> None
dividendRate >>> None
exDividendDate >>> None
beta >>> 1.081325
circulatingSupply >>> None
startDate >>> None
regularMarketDayLow >>> 31.6
priceHint >>> 2
currency >>> USD
regularMarketVolume >>> 135991
lastMarket >>> None
maxSupply >>> None
openInterest >>> None
marketCap >>> 4478117888
volumeAllCurrencies >>> None
strikePrice >>> None
averageVolume >>> 300312
priceToSalesTrailing12Months >>> 21.37955
dayLow >>> 31.6
ask >>> 32.73
ytdReturn >>> None
askSize >>> 800
volume >>> 135991
fiftyTwoWeekHigh >>> 34.9
forwardPE >>> -41.64557
fromCurrency >>> None
fiveYearAvgDividendYield >>> None
fiftyTwoWeekLow >>> 14.74
bid >>> 32.36
tradeable >>> False
dividendYield >>> None
bidSize >>> 800
dayHigh >>> 32.9
exchange >>> NMS
shortName >>> Hutchison China MediTech Limite
longName >>> Hutchison China MediTech Limited
exchangeTimezoneName >>> America/New_York
exchangeTimezoneShortName >>> EDT
isEsgPopulated >>> False
gmtOffSetMilliseconds >>> -14400000
quoteType >>> EQUITY
symbol >>> HCM
messageBoardId >>> finmb_26652603
market >>> us_market
annualHoldingsTurnover >>> None
enterpriseToRevenue >>> 20.52
beta3Year >>> None
profitMargins >>> -0.52682996
enterpriseToEbitda >>> -29.222
52WeekChange >>> 0.84417045
morningStarRiskRating >>> None
forwardEps >>> -0.79
revenueQuarterlyGrowth >>> None
sharesOutstanding >>> 142119008
fundInceptionDate >>> None
annualReportExpenseRatio >>> None
bookValue >>> 2.49
sharesShort >>> 1265382
sharesPercentSharesOut >>> 0.0089
fundFamily >>> None
lastFiscalYearEnd >>> 1577750400
heldPercentInstitutions >>> 0.3065
netIncomeToCommon >>> -110349000
trailingEps >>> -0.82
lastDividendValue >>> None
SandP52WeekChange >>> 0.108078
priceToBook >>> 13.212852
heldPercentInsiders >>> 0.066
nextFiscalYearEnd >>> 1640908800
mostRecentQuarter >>> 1593475200
shortRatio >>> 3.4
sharesShortPreviousMonthDate >>> 1596153600
floatShares >>> 62120958
enterpriseValue >>> 4298039808
threeYearAverageReturn >>> None
lastSplitDate >>> 1559174400
lastSplitFactor >>> 1:1
legalType >>> None
morningStarOverallRating >>> None
earningsQuarterlyGrowth >>> None
dateShortInterest >>> 1598832000
pegRatio >>> 0.88
lastCapGain >>> None
shortPercentOfFloat >>> None
sharesShortPriorMonth >>> 1013401
category >>> None
fiveYearAverageReturn >>> None
regularMarketPrice >>> 31.68
logo_url >>> https://logo.clearbit.com/chi-med.com
